http://www.drugrecalllawyerblog.com/ Published By Miller & Zois en-us 2010-03-11T07:28:21-05:00 http://www.drugrecalllawyerblog.com/2010/03/the_supremes_examine_vaccines.html In Bruesewitz v. Wyeth, the plaintiffs are appealing to the United States Supreme Court from the Third Circuit Court of Appeals. They believe that the administrative set-up of the National Childhood Vaccine Injury Act (est’d 1988) is an insufficient remedy... Vaccines John J. Cord 2010-03-11T07:28:21-05:00 http://www.drugrecalllawyerblog.com/2010/03/seroquel_trial_update.html The New Jersey Superior Court Case (Middlesex County) of Baker v. AstraZeneca Pharmaceuticals LP is now focusing on the drug manufacturer’s advertising strategy. The plaintiff in that case is alleging that he should have been better warned about the risks... John J. Cord 2010-03-10T09:05:55-05:00 http://www.drugrecalllawyerblog.com/2010/03/drug_recall_lawyer_blog_roundu_3.html Time to wake up and face the week! Here are the stories we’re following: Avandia: The U.K.’s Guardian blogs about GlaxoSmithKline’s potential $6 billion liability. @TomLamb and I are skeptical. Vioxx: Australian judge finds for plaintiff in defective drug lawsuit... John J. Cord 2010-03-08T03:48:18-05:00 http://www.drugrecalllawyerblog.com/2010/03/avandia_much_ado_about_nothing_1.html Yesterday I clicked a link from @pharmaguy: End-of-Life Warning at $618,616 Makes Me Wonder Was It Worth It, an article in Bloomberg by Amanda Bennett. Don’t read it unless you have 5-10 minutes of quiet time—this is a powerful story.... John J. Cord 2010-03-05T04:30:25-05:00 http://www.drugrecalllawyerblog.com/2010/03/avandia_much_ado_about_nothing.html Today’s New York Times featured commentary by Dr. Gilbert Ross (maybe this Gilbert Ross?). “When Senators Play Doctor: Risk-mongering can stifle innovation, cost lives.” Dr. Ross essentially argues that the senators have completely misinterpreted the Avandia data, whether intentionally or... John J. Cord 2010-03-04T11:48:11-05:00 http://www.drugrecalllawyerblog.com/2010/03/bigpharma_goes_all_social_medi.html Up until now, online social networking has been treated mostly as a plaything for some pharmaceutical manufacturers. They will post a few updates on Twitter, maybe start a Facebook page or post a YouTube video or two, but I have... Social Networking John J. Cord 2010-03-02T09:28:32-05:00 http://www.drugrecalllawyerblog.com/2010/03/drug_recall_lawyer_blog_roundu_1.html Here are this week’s stories: 2009 Adverse Event Reports: Avandia (GlaxoSmithKline) and Seroquel (AstraZeneca) topped the charts for most adverse events for the third quarter of 2009, with 1,218 reports and 977 reports, respectively. See The Institute for Safe Medicine... John J. Cord 2010-03-01T09:02:53-05:00 http://www.drugrecalllawyerblog.com/2010/02/yaz_new_jersey_state_court_cas.html On November 10, 2009 we wrote that New Jersey state court Assignment Judge Donald Volkert, Jr. formally requested consolidation of the YAZ, Yasmin and Ocella birth control lawsuits in New Jersey state courts. In an order dated February 9,... John J. Cord 2010-02-26T08:54:01-05:00 http://www.drugrecalllawyerblog.com/2010/02/recent_hormone_therapy_trials.html Since Monday, there have been decisions in two hormone therapy cases. Here are the details: Monday, February 22-Audrey Singleton: In the Philadelphia Court of Common Pleas, a jury found for the Plaintiff and against Pfizer/Wyeth. The verdict, which came after... Wyeth John J. Cord 2010-02-25T08:37:15-05:00 http://www.drugrecalllawyerblog.com/2010/02/avandia_lawsuits_recall_and_up.html If my Google Reader subscriptions are any indication, about 50% of the new blog posts across the web in the past couple of days have been about Avandia. This post is intended as a hub for basic information on Avandia... GlaxoSmithKline John J. Cord 2010-02-24T10:23:20-05:00